US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward
Executive Summary
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.
You may also be interested in...
FDA-Sponsor Interaction Could Increase Post-Pandemic With Virtual, In-Person Options
Scott Gottlieb says that some meetings should remain in-person, but with virtual options proven effective, the FDA could offer more opportunities to talk to sponsors.
Robert Califf’s Chance To Make History At The US FDA
Robert Califf’s first tenure as US FDA Commissioner was decidedly anti-climactic. His return trip – assuming the Senate confirms him – will be potentially transformational: he will be the leader that defines what FDA is after COVID.
Adcomm Member Survey Shows Continued Support For Virtual Meetings After Pandemic
Despite acknowledging that fully in-person meetings overall are better, survey respondents said they still want the flexibility that virtual attendance offers.